Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


 

Methanol Extract of Myelophycus caespitosus Inhibits the Inflammatory Response in Lipopolysaccharide-stimulated BV2 Microglial Cells by Downregulating NF-κB via Inhibition of the Akt Signaling Pathway

Rajapaksha Gendara Prasad Tharanga Jayasooriya1, Chang-Hee Kang1, Yeon-Jeong Jang1, Sang-Hyuck Kang1, Matharage Gayani Dilshara1, Yung Hyun Choi2, Dong-Oh Moon3 and Gi-Young Kim1*

1Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, 2Department of Biochemistry, College of Oriental Medicine, Dongeui University, Busan 614-054, 3Department of Biology Education, College of Education, Gyeongsan, Gyeongbuk 712-714, Republic of Korea.

*For correspondence: Email: immunkim@jejunu.ac.kr  Tel: +82 64 754 3427; Fax: +82 64 756 3493

Received:  26 March 2012                                        Revised accepted: 8 October 2012

Tropical Journal of Pharmaceutical Research, December 2012; 11(6): 917-924

http://dx.doi.org/10.4314/tjpr.v11i6.7  

Abstract

 

Purpose: To determine whether the methanol extract of Myelophycus caespitosus (MEMC) downregulates the expression of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated BV2 microglial cells.

Methods: Reverse transcription-polymerase chain reaction (RT-PCR) together with Western blot analysis was used to evaluate the expression of pro-inflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2) as well as their regulatory genes such as inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), in LPS-stimulated BV2 microglial cells. The level of NO production was analyzed using Griess reaction. The release of PGE2 was determined using sandwich enzyme-linked immunosorbent assay. The DNA-binding activity of nuclear factor-κB (NF-κB) was measured by electrophoretic mobility shift assay.

Results: MEMC inhibited LPS-induced pro-inflammatory mediators, NO and PGE2, as well as their respective genes, iNOS and COX-2, at both protein and mRNA levels, without any significant cytotoxicity. Treatment with MEMC also substantially reduced the LPS-induced DNA-binding activity of NF-κB and nuclear translocation of NF-κB subunits p65 and p50 via the inhibition of IκBα phosphorylation and degradation. MEMC promoted dephosphorylation of Akt that subsequently suppressed the DNA-binding activity of NF-κB in LPS-stimulated BV2 microglial cells.

Conclusion: Collectively, these data suggest that MEMC attenuates expression of pro-inflammatory mediators such as NO and PGE2 by suppression of their regulatory genes through the inhibition of Akt-mediated NF-κB activity.

 

Keywords: Myelophycus caespitosus, Nitric oxide, Prostaglandin E2, Nuclear factor-κB.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net